Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CEVI.ST Stock Summary
Top 10 Correlated ETFs
CEVI.ST
In the News
CEVI.ST Financial details
Company Rating
Strong Buy
Market Cap
5.2B
Income
130.31M
Revenue
677.29M
Book val./share
30.04
Cash/share
5.1
Dividend
2.25
Dividend %
1.07%
Employees
228
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
44.65
Forward P/E
26.12
PEG
43.42
P/S
7.96
P/B
7.39
P/C
46.86
P/FCF
83.32
Quick Ratio
0.65
Current Ratio
2.77
Debt / Equity
0.09
LT Debt / Equity
0.04
-
-
EPS (TTM)
5.47
EPS next Y
9.15
EPS next Q
1.61
EPS this Y
10.08%
EPS next Y
67.21%
EPS next 5Y
104.41%
EPS last 5Y
5.59%
Revenue last 5Y
7.96%
Revenue Q/Q
19.5%
EPS Q/Q
93.58%
-
-
-
-
SMA20
-8.3%
SMA50
12.62%
SMA100
65.71%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
17%
ROC
0.19%
Gross Margin
68%
Oper. Margin
23%
Profit Margin
18%
Payout
48%
Shs Outstand
23.85M
Shs Float
14.76M
-
-
-
-
Target Price
-
52W Range
120.0-275.0
52W High
-13.09%
52W Low
+99.17%
RSI
55
Rel Volume
0.09
Avg Volume
21.76K
Volume
1.87K
Perf Week
3.24%
Perf Month
-9.64%
Perf Quarter
66.2%
Perf Half Y
49.38%
-
-
-
-
Beta
1.101
-
-
Volatility
7.51%, 12.41%
Prev Close
0%
Price
239
Change
0.84%
CEVI.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.36 | 19.77 | 23.71 | 26.8 | 28.4 | |
Net income per share | 4.16 | 3.75 | 5.25 | 4.96 | 5.46 | |
Operating cash flow per share | 5.28 | 2.98 | 6.7 | 5.76 | 8.24 | |
Free cash flow per share | 4.5 | 1.57 | 3.16 | 2.84 | 4.61 | |
Cash per share | 3.54 | 3.56 | 4.55 | 4.31 | 5.1 | |
Book value per share | 14.61 | 18.01 | 22.78 | 26.9 | 30.04 | |
Tangible book value per share | 2.04 | 5.4 | 7.76 | 10.16 | 24.85 | |
Share holders equity per share | 14.61 | 18.01 | 22.78 | 26.9 | 30.04 | |
Interest debt per share | 7.34 | 5.67 | 5.81 | 4.4 | 3.14 | |
Market cap | 7.62B | 7.32B | 7.76B | 5.46B | 5.06B | |
Enterprise value | 7.69B | 7.35B | 7.76B | 5.46B | 5B | |
P/E ratio | 76.84 | 81.83 | 61.89 | 46.16 | 38.8 | |
Price to sales ratio | 16.5 | 15.53 | 13.72 | 8.54 | 7.47 | |
POCF ratio | 60.49 | 102.95 | 48.57 | 39.79 | 25.74 | |
PFCF ratio | 71.02 | 195.44 | 102.86 | 80.5 | 45.99 | |
P/B Ratio | 21.88 | 17.04 | 14.28 | 8.51 | 7.06 | |
PTB ratio | 21.88 | 17.04 | 14.28 | 8.51 | 7.06 | |
EV to sales | 16.66 | 15.6 | 13.73 | 8.53 | 7.38 | |
Enterprise value over EBITDA | 50.98 | 50.09 | 40.1 | 28.59 | 25.02 | |
EV to operating cash flow | 61.05 | 103.38 | 48.6 | 39.75 | 25.45 | |
EV to free cash flow | 71.68 | 196.25 | 102.94 | 80.42 | 45.47 | |
Earnings yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Debt to equity | 0.5 | 0.31 | 0.25 | 0.16 | 0.09 | |
Debt to assets | 0.27 | 0.2 | 0.17 | 0.11 | 0.07 | |
Net debt to EBITDA | 0.47 | 0.21 | 0.03 | -0.03 | -0.28 | |
Current ratio | 2.11 | 2.86 | 2.71 | 2.83 | 3.07 | |
Interest coverage | 84.67 | 43.31 | 87.21 | 67.64 | 16.32 | |
Income quality | 0.98 | 0.63 | 1.01 | 0.92 | 1.51 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.36 | 0 | 0.14 | 0.4 | 0.41 | |
Sales general and administrative to revenue | 0.11 | 0.11 | 0.11 | 0.12 | 0 | |
Research and developement to revenue | 0.12 | 0.11 | 0.11 | 0.14 | 0.12 | |
Intangibles to total assets | 0.47 | 0.45 | 0.43 | 0.45 | 0.13 | |
Capex to operating cash flow | -0.15 | -0.47 | -0.53 | -0.51 | -0.44 | |
Capex to revenue | -0.04 | -0.07 | -0.15 | -0.11 | -0.13 | |
Capex to depreciation | -0.93 | -1.05 | -2.52 | -1.73 | -2.64 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 36.96 | 38.99 | 51.89 | 54.8 | 60.76 | |
ROIC | 0.18 | 0.15 | 0.18 | 0.17 | 0.17 | |
Return on tangible assets | 0.29 | 0.24 | 0.27 | 0.24 | 0.16 | |
Graham Net | -4.32 | -1.26 | -1.23 | 0.65 | 2.55 | |
Working capital | 139.39M | 193.92M | 230.22M | 244.05M | 246.44M | |
Tangible asset value | 48.71M | 128.73M | 185.12M | 242.4M | 592.61M | |
Net current asset value | -28.09M | 59.66M | 82.79M | 127.02M | 153.27M | |
Invested capital | 0.5 | 0.31 | 0.25 | 0.16 | 0.09 | |
Average receivables | 52.32M | 106.67M | 112.09M | 118.69M | 119.9M | |
Average payables | 24.23M | 21.29M | 32.86M | 46.36M | 40.2M | |
Average inventory | 44.63M | 69.23M | 99.37M | 128.83M | 134.3M | |
Days sales outstanding | 82.71 | 84.15 | 74.54 | 69.59 | 63.54 | |
Days payables outstanding | 63.39 | 48.08 | 94.51 | 86.91 | 55.43 | |
Days of inventory on hand | 159.99 | 192.77 | 242.47 | 258.87 | 214.72 | |
Receivables turnover | 4.41 | 4.34 | 4.9 | 5.25 | 5.74 | |
Payables turnover | 5.76 | 7.59 | 3.86 | 4.2 | 6.59 | |
Inventory turnover | 2.28 | 1.89 | 1.51 | 1.41 | 1.7 | |
ROE | 0.28 | 0.21 | 0.23 | 0.18 | 0.18 | |
Capex per share | -0.78 | -1.41 | -3.53 | -2.91 | -3.63 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.39 | 5.83 | 7.11 | 7.04 | 8.41 | |
Net income per share | 1.35 | 0.81 | 1.46 | 1.09 | 2.11 | |
Operating cash flow per share | 1.18 | 0.78 | 1.19 | 3.06 | 3.2 | |
Free cash flow per share | 0.13 | -0.19 | 0.28 | 2.3 | 2.22 | |
Cash per share | 4.31 | 3.9 | 1.46 | 3.31 | 5.1 | |
Book value per share | 26.9 | 27.85 | 27.66 | 28.42 | 30.04 | |
Tangible book value per share | 10.16 | 10.65 | 9.65 | 10.35 | 24.85 | |
Share holders equity per share | 26.9 | 27.85 | 27.66 | 28.42 | 30.04 | |
Interest debt per share | 3.82 | 5.72 | 5.74 | 5.27 | 2.85 | |
Market cap | 5.46B | 4.41B | 4.38B | 3.66B | 5.06B | |
Enterprise value | 5.46B | 4.45B | 4.48B | 3.71B | 5B | |
P/E ratio | 42.28 | 57.43 | 31.54 | 35.28 | 25.07 | |
Price to sales ratio | 35.86 | 31.72 | 25.81 | 21.82 | 25.2 | |
POCF ratio | 193.94 | 237.36 | 154.06 | 50.19 | 66.17 | |
PFCF ratio | 1.74K | -994.71 | 656.15 | 66.92 | 95.45 | |
P/B Ratio | 8.51 | 6.64 | 6.64 | 5.4 | 7.06 | |
PTB ratio | 8.51 | 6.64 | 6.64 | 5.4 | 7.06 | |
EV to sales | 35.82 | 32.02 | 26.39 | 22.09 | 24.92 | |
Enterprise value over EBITDA | 189.68 | 171.06 | 92.93 | 110.2 | 70.63 | |
EV to operating cash flow | 193.74 | 239.61 | 157.51 | 50.81 | 65.42 | |
EV to free cash flow | 1.74K | -1K | 670.86 | 67.75 | 94.37 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Debt to equity | 0.16 | 0.2 | 0.2 | 0.18 | 0.09 | |
Debt to assets | 0.11 | 0.15 | 0.15 | 0.14 | 0.07 | |
Net debt to EBITDA | -0.19 | 1.6 | 2.04 | 1.35 | -0.8 | |
Current ratio | 2.83 | 3.07 | 2.58 | 2.77 | 3.07 | |
Interest coverage | -3.45 | 14.89 | 12.02 | 22.15 | 19.46 | |
Income quality | 0.7 | 0.76 | 0.64 | 2.27 | 1.52 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.55 | 0 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.13 | 0.11 | 0.11 | 0 | |
Research and developement to revenue | 0.13 | 0.14 | 0.12 | 0.14 | 0.1 | |
Intangibles to total assets | 0.45 | 0.46 | 0.48 | 0.48 | 0.13 | |
Capex to operating cash flow | -0.89 | -1.24 | -0.77 | -0.25 | -0.31 | |
Capex to revenue | -0.16 | -0.17 | -0.13 | -0.11 | -0.12 | |
Capex to depreciation | -0.66 | -2.42 | -2.21 | -2.23 | -2.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 28.63 | 22.46 | 30.09 | 26.38 | 37.8 | |
ROIC | 0.04 | 0.02 | 0.05 | 0.03 | 0.06 | |
Return on tangible assets | 0.07 | 0.04 | 0.07 | 0.06 | 0.06 | |
Graham Net | 0.65 | 1.03 | -0.65 | 0.78 | 2.55 | |
Working capital | 244.05M | 244.5M | 207.31M | 213.18M | 246.44M | |
Tangible asset value | 242.4M | 253.95M | 230.18M | 246.87M | 592.61M | |
Net current asset value | 127.02M | 129.89M | 99.65M | 117.14M | 153.27M | |
Invested capital | 0.16 | 0.2 | 0.2 | 0.18 | 0.09 | |
Average receivables | 106.84M | 119.73M | 131.95M | 130.86M | 116.64M | |
Average payables | 41.33M | 41.98M | 38.53M | 34.03M | 29.82M | |
Average inventory | 136.37M | 147.3M | 154.48M | 148.21M | 132.76M | |
Days sales outstanding | 72.02 | 76.07 | 77.62 | 61.85 | 52.89 | |
Days payables outstanding | 85.02 | 76.93 | 72.51 | 43.19 | 45.25 | |
Days of inventory on hand | 253.25 | 323.96 | 277.84 | 222.3 | 175.3 | |
Receivables turnover | 1.25 | 1.18 | 1.16 | 1.46 | 1.7 | |
Payables turnover | 1.06 | 1.17 | 1.24 | 2.08 | 1.99 | |
Inventory turnover | 0.36 | 0.28 | 0.32 | 0.4 | 0.51 | |
ROE | 0.05 | 0.03 | 0.05 | 0.04 | 0.07 | |
Capex per share | -1.05 | -0.97 | -0.91 | -0.77 | -0.98 |
CEVI.ST Frequently Asked Questions
What is CellaVision AB (publ) stock symbol ?
CellaVision AB (publ) is a SE stock and trading under the symbol CEVI.ST
What is CellaVision AB (publ) stock quote today ?
CellaVision AB (publ) stock price is $239 today.
Is CellaVision AB (publ) stock public?
Yes, CellaVision AB (publ) is a publicly traded company.